CAMBRIDGE, Mass., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that management will deliver a corporate presentation at two upcoming healthcare conferences: Canaccord 30th Annual Global Growth Conference and the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference.
| Momenta's presentation schedule is as follows: | |
|
* Canaccord 30th Annual Global Conference Thursday, August 12th at 10:00am ET, the InterContinental Boston, Boston, Massachusetts |
|
|
* Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Thursday, August 12th at 1:40pm ET, the Southhampton Inn, Southhampton, NY |
|
Live audio webcasts of each presentation will be available on the "Investors" section of the Company's website located at www.momentapharma.com. A replay of each presentation will be posted on the Momenta website approximately one hour after each event and will be available for 90 days.
About Momenta
Momenta Pharmaceuticals is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.
To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.
Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.